Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
暂无分享,去创建一个
Matthias Kittelmann | S. Lütz | K. Schroer | Stephan Lütz | Kirsten Schroer | M. Kittelmann | Kirsten Schroer
[1] B. Brodie,et al. Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. , 1954, The Journal of biological chemistry.
[2] Y. Hiraoka,et al. Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1. , 2002, Biochemistry.
[3] F. Guengerich,et al. Cytochrome p450 enzymes in the generation of commercial products , 2002, Nature Reviews Drug Discovery.
[4] F. Guengerich,et al. Cytochrome P450s and other enzymes in drug metabolism and toxicity , 2006, The AAPS Journal.
[5] J. Ishikawa,et al. Hydroxylation of Testosterone by Bacterial Cytochromes P450 Using the Escherichia coli Expression System , 2006, Bioscience, biotechnology, and biochemistry.
[6] C. Wolf,et al. Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. , 1999, Drug metabolism reviews.
[7] F. Peters,et al. Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine. , 2009, Forensic science international.
[8] M. White,et al. A Predictably Selective Aliphatic C–H Oxidation Reaction for Complex Molecule Synthesis , 2007, Science.
[9] F Peter Guengerich,et al. Cytochromes P450, drugs, and diseases. , 2003, Molecular interventions.
[10] Y. Uno,et al. Bioconversion of small molecules by cytochrome P450 species expressed in Escherichia coli , 2008, Biotechnology and applied biochemistry.
[11] F. Arnold,et al. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. , 2006, Biotechnology and bioengineering.
[12] M. Berenbaum,et al. Modifications in the N-terminus of an insect cytochrome P450 enhance production of catalytically active protein in baculovirus-Sf9 cell expression systems. , 2008, Insect biochemistry and molecular biology.
[13] C. Wolf,et al. Recombinant Yeast and Bacteria that Express Human P450s: Bioreactors for Drug Discovery, Development, and Biotechnology , 2007 .
[14] R Scott Obach,et al. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. , 2009, Chemical research in toxicology.
[15] K. Korzekwa,et al. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. , 1994, Drug metabolism and disposition: the biological fate of chemicals.
[16] W. Humphreys,et al. Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery. , 2004, Journal of medicinal chemistry.
[17] S. Surapaneni,et al. Role of drug metabolism in drug discovery and development , 2001, Medicinal research reviews.
[18] Magnus Ingelman-Sundberg,et al. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. , 2004, Trends in pharmacological sciences.
[19] T. Rushmore,et al. Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites. , 2000, Metabolic engineering.
[20] P. Beaune,et al. Recombinant yeast in drug metabolism. , 1993, Toxicology.
[21] T. Ahn,et al. Functional expression of human cytochrome P450 enzymes in Escherichia coli. , 2006, Current drug metabolism.
[22] C. Wolf,et al. A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. , 1997, Archives of biochemistry and biophysics.
[23] Imad Hanna,et al. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli , 2005, Journal of Industrial Microbiology and Biotechnology.
[24] R. Bernhardt,et al. Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.
[25] S. Lütz,et al. Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe. , 2010, Journal of biotechnology.
[26] K. Auclair,et al. Progress towards the easier use of P450 enzymes. , 2006, Molecular bioSystems.
[27] V. Urlacher,et al. Cytochrome P450 BM-3 Evolved by Random and Saturation Mutagenesis as an Effective Indole-Hydroxylating Catalyst , 2008, Applied biochemistry and biotechnology.
[28] C. Wolf,et al. In Vivo and In Vitro Recombinant DNA Technology as a Powerful Tool in Drug Development , 1999 .
[29] Michael D. Coleman,et al. Human Drug Metabolism , 2020 .
[30] F. Gonzalez,et al. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. , 1991, Carcinogenesis.